The heart in Anderson-Fabry disease

S Sestito; K Roppa; F Parisi; M T Moricca; L Pensabene; R Chimenz; M D Ceravolo; U Cucinotta; G Ceravolo; M P Calabrò; C Cuppari; P Mondello; D Musolino; V Tallarico; D Concolino

The heart in Anderson-Fabry disease

J Biol Regul Homeost Agents. 2020 Jul-Aug;34(4 Suppl. 2):63-69. SPECIAL ISSUE: FOCUS ON PEDIATRIC CARDIOLOGY.

Authors

S Sestito¹, K Roppa¹, F Parisi¹, M T Moricca¹, L Pensabene¹, R Chimenz², M D Ceravolo³, U Cucinotta³, G Ceravolo³, M P Calabrò⁴, C Cuppari³, P Mondello⁵, D Musolino¹, V Tallarico¹, D Concolino¹

Affiliations

¹ Pediatric Unit, Department of Science of Health, University Magna Graecia of Catanzaro, Catanzaro, Italy.
² Department of Human Pathology in Adult and Developmental Age "Gaetano Barresi", Unit of Pediatric Nephrology, University of Messina, "G. Martino" Policlinic, Italy.
³ Department of Human Pathology in Adult and Developmental Age "Gaetano Barresi", Unit of Emergency Pediatrics, University of Messina, Policlinico "G. Martino" Messina, Italy.
⁴ Department of Human Pathology in Adult and Developmental Age "Gaetano Barresi", Unit of Pediatric Cardiology, University of Messina, "G. Martino" Policlinic, Italy.
⁵ Division of Hematology, Department of Human Pathology in Adulthood and Childhood "Gaetano Barresi", University of Messina, 98125 Messina, Italy.

PMID: 33000603

No abstract available

Keywords: Anderson-Fabry disease (AFD); Arrhythmias; Cardiomyopathy; Enzyme Replacement Therapy (ERT); GLA gene; Left Ventricular Hypertophy (LVH); valve disease; α-galactosidase A.

Publication types

Letter

MeSH terms

Fabry Disease* / genetics
Heart
Humans
alpha-Galactosidase / genetics

Substances

alpha-Galactosidase